Abstract: A heterocyclic compound represented by Formula 1, an organic light-emitting device including the heterocyclic compound, and an electronic apparatus: wherein, in Formula 1, Cz1 is a group represented by Formula 2, k1 to k3 are each independently 0, 1, 2, 3, 4, or 5, and a sum of k1 to k3 is 1 or greater, and wherein the descriptions of the remaining substituents in Formula 1 and Formula 2 are as provided herein.

Abstract: Provided are a condensed cyclic compound, a light-emitting device including the same, and an electronic apparatus including the light-emitting device, the condensed cyclic compound including a first boron, a second boron, ring A1, ring A2, ring A3, ring A4, and ring A5, and having a percent volume buried (% Vbur) of 65% or more with respect to the center of highest occupied natural transition orbital (HONTO).

Abstract: Provided are an organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound: M1(L11)n11(L12)n12??Formula 1 wherein L11 in Formula 1 is a ligand represented by Formula 1-1: wherein, in Formula 1-1, Ar1 is a phenyl group substituted with at least one of E1 and Ar2 is a phenyl group substituted with at least one E2, and the other substituents are described in the detailed description of the present specification.

Abstract: Provided are a heterocyclic compound represented by Formula 1, an organic light-emitting device including the same, and an electronic apparatus including the organic light-emitting device. The detailed description of Formula 1 is the same as described in the present specification.

Abstract: An organometallic compound, represented by Formula 1: wherein, M1 is a transition metal, X10, X11, X20, X30, and X40 are each independently C or N, provided that one of X10 and X11 is N, and the other of X10 and X11 is C, ring A10 is a C5-C30 carbocyclic group or a C1-C30 heterocyclic group, wherein each of X12 and X13 is C, or when ring A10 is not present, X12 is C(R11) and X13 is C(R12), ring A11 is a pyrazole ring or an imidazole ring, rings A20, A30, and A40 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group, and at least one of R10, R11, R12, R20, R30, or R40 is a group represented by Formula 2: wherein the remaining substituent groups are as described herein.

Abstract: Provided are a heterocyclic compound represented by Formula 1, an organic light-emitting device including the heterocyclic compound, and an electronic apparatus including the organic light-emitting device: wherein Formula 1 may be understood by referring to the description of Formula 1 provided herein.

Abstract: Provided are a condensed cyclic compound represented by Formula 1, a light-emitting device including the same, and an electronic apparatus including the light-emitting device: wherein a detailed description of Formula 1 is provided in the present specification.

Abstract: Provided are the organometallic compound represented by Formula 1 and an organic light-emitting device including the same: M, X1 to X4, X11, ring CY2 to ring CY4, T1, T2, R1 to R4, and a1 to a4 in Formula 1 are the same as described in the present specification.

Abstract: A heterocyclic compound represented by Formula 1 and an organic light-emitting device including the same:

Abstract: An organometallic compound represented by Formula 1: wherein, M1 is a transition metal; X11 is N or C(R11); X12 is N or C(R12); X21 is N or C(R21); X22 is N or C(R22); X23 is N or C(R23); at least one of X21 and X22 is N; Y2 to Y4 are each independently C or N; A2 to A4 are each independently a chemical bond, O, or S; ring CY3 and ring CY4 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group; a1, a2, and a3 are each independently an integer from 1 to 3; R13 is a group represented by Formula 2, and the remaining substituents are as defined herein.

Abstract: An organometallic compound represented by Formula 1-1 or 1-2: wherein, in Formulae 1-1 and 1-2, M is Pt or Pd; each of X1, X2, and X3 is carbon; X4 is nitrogen; T8 is O, S, N(R81), C(R81)(R82), or Si(R81)(R82); and the remaining substituent groups are as defined herein.

Abstract: Provided are a heterocyclic compound represented by Formula 1, an organic light-emitting device including the same, and a diagnostic composition including the heterocyclic compound as described in the detailed description.

Abstract: Provided are the organometallic compound represented by Formula 1 and an organic light-emitting device including the same: M, X1 to X4, X11, ring CY2 to ring CY4, T1, T2, R1 to R4, and a1 to a4 in Formula 1 are the same as described in the present specification.

Abstract: An organometallic compound represented by Formula 1: wherein, M is a transition metal, X11 is N or C(R11), X12 is N or C(R12), at least one of X11 and X12 is N, ring CY2, ring CY31, ring CY32, and ring CY4 are each independently a C3-C60 carbocyclic group or a C1-C60 heterocyclic group, Y2 to Y4 are each independently C or N, A2 to A4 are each independently a chemical bond, O, or S, a1 to a3 are each independently an integer from 1 to 3, and the remaining substitutions are as provided in the detailed description.

Abstract: Provided are the organometallic compound represented by Formula 1 and an organic light-emitting device including the same: M, X1 to X4, X11, ring CY2 to ring CY4, T1, T2, R1 to R4, and a1 to a4 in Formula 1 are the same as described in the present specification.

Abstract: An organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound are provided: M1(L11)n11(L12)n12??Formula 1 wherein, in Formula 1, L11 may be a ligand represented by Formula 1-1, and the other substituents may be understood by referring to the descriptions thereof provided in the detailed description:

Abstract: Provided are a light-emitting device and an electronic apparatus including the same, the light-emitting device including a first electrode, a second electrode, and an interlayer arranged between the first electrode and the second electrode and including an emission layer, wherein the emission layer includes a first compound represented by Formula 1 and a second compound represented by Formula 2: wherein details of Formulae 1 and 2 are as described herein.

Abstract: Provided are an organometallic compound, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound.

Abstract: Provided are an organometallic compound represented by Formula 1 and an organic light-emitting device including the same: wherein the detailed description of Formula 1 is the same as described in the present specification.

Abstract: An organometallic compound, represented by Formula 1: wherein, M1 is a transition metal, X10, X11, X20, X30, and X40 are each independently C or N, provided that one of X10 and X11 is N, and the other of X10 and X11 is C, ring A10 is a C5-C30 carbocyclic group or a C1-C30 heterocyclic group, wherein each of X12 and X13 is C, or when ring A10 is not present, X12 is C(R11) and X13 is C(R12), ring A11 is a pyrazole ring or an imidazole ring, rings A20, A30, and A40 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group, and at least one of R10, R11, R12, R20, R30, or R40 is a group represented by Formula 2: wherein the remaining substituent groups are as described herein.